Thereby guaranteeing the optimal design of every clinical trial for success. We engage in comprehensive discussions with investigators and sites to gauge early feasibility, assessing factors such as investigatory alignment, investigator engagement, patient accessibility, enrolment projections, and study site capabilities.
